Courtesy of Klug Law Firm.

On November 23, 2020, U.S. District Judge Jeffrey S. White heard arguments focused on a single question: Did the Department of Homeland Security (DHS) and Department of Labor (DOL) have “good cause” to bypass standard rulemaking procedures and publish emergency regulations to restrict H-1B visas? The plaintiffs – businesses and universities led by the U.S. Chamber of Commerce – argued case law, economic data and the Trump administration’s actions show good cause did not exist. The DOL rule took effect on October 8, 2020, and the DHS rule is effective December 7, 2020, unless blocked. The plaintiffs are asking the court to vacate both regulations.

The Administrative Procedure Act (APA) requires federal agencies to provide notice and the opportunity to comment before a regulation goes into effect. The Trump administration published the DHS and DOL H-1B rules “interim final” and claimed “good cause” reasons existed that justified the agencies publishing the regulations (and allowing them to go into effect) before allowing the public to comment. This is the central dispute between businesses and universities and the Trump administration in U.S. Chamber of Commerce et al. v. DHS et al. – whether the economic situation created by the coronavirus pandemic provides DHS and DOL with a “good cause” exception for its actions.

Paul Hughes of McDermott Will & Emery, the lead counsel for plaintiffs in the Chamber lawsuit, emphasized the high stakes during the November 23rd hearing. “We think this is an overt attempt to destroy the H-1B program,” said Hughes, and several company executives and university leaders provided declarations to that effect. Zane Brown said, “Many of Amazon’s most tenured employees,” including data scientists and software engineers, would have to leave the United States. At the same time, Hughes cited the reliance issue for the University of Utah and its 350 H-1B visa holders, five hospitals and 12 clinics. The university’s attorney said the DHS rule would cause “substantial irreparable harm.”

Hughes also cited the Trump administration as a source. Ken Cuccinelli at the Department of Homeland Security said up to 200,000 H-1B professionals could lose their jobs under the rule. The Department of Labor estimated its rule, which inflates H-1B wage requirements by 40% or more, would cost employers $198 billion over 10 years, making it potentially the most expensive regulation imposed on businesses in modern U.S. history, based on an analysis by the U.S. Chamber of Commerce.

During the court hearing, held via Zoom, the Trump administration did not offer strong responses to arguments plaintiffs put forward in their reply brief or in court. Below are the arguments central to the case.

First, at the hearing, Paul Hughes noted the DHS and DOL rules failed to connect the H-1B visa category to the coronavirus-related economic problems. He pointed to a National Foundation for American Policy (NFAP) analysis of Bureau of Labor Statistics data that showed: “The U.S. unemployment rate for individuals in computer occupations stood at 3.5% in September 2020, not changed significantly from the 3% unemployment rate in January 2020 (before the pandemic spread in the U.S.).” Hughes also noted from the NFAP analysis that there were over 655,000 active job vacancy postings advertised online in computer occupations in the United States as of October 2, 2020.

The data cited by Hughes was available to DHS and DOL before issuing the rules, along with DHS statistics that show most H-1B visa holders work in computer occupations. Hughes successfully litigated for a preliminary injunction against the Trump administration’s June 2020 proclamation (which restricted the entry of H-1B, L-1 and other visa holders). In granting the preliminary injunction in October (NAM v. DHS), Judge White cited NFAP research and other evidence indicating Covid-19 unemployment problems were not focused in computer jobs. During the November 23rd hearing, Hughes noted the government had an even higher burden of proof to show a “good cause” exception for its two recent rules than the standard it used to defend (unsuccessfully) the president’s authority to issue the June 2020 proclamation.

Second, the Trump administration’s attorney offered a limited response to the plaintiffs’ point that DHS and DOL did not address the lack of connection to H-1B visas and coronavirus-related unemployment. The government’s attorney repeated the argument in the DHS rule that the unemployment rate had increased in the Information sector and the Professional and Business Services sector. Hughes responded, citing the National Foundation for American Policy report, that these “sectors” include all employees of a company – and only approximately 10% of the jobs (computer occupations with a B.S. or higher) in the sectors are in occupations similar to professionals in the H-1B category.

The Trump administration’s attorney argued DHS was focused on the “health of the sectors.” Yet that argument appeared weak in light of the impact of the DHS and DOL rules: How would imposing $198 billion in additional regulatory costs on companies in these sectors improve the “health of the sectors”?

Third, the administration also did not appear to successfully respond to the plaintiffs’ argument that DHS and DOL waited more than 6 months to issue rules after the national unemployment rate reached its height in April 2020. “Courts routinely reject claims of good cause when an agency delays promulgating a rule in the face of an emergency and then claims that that very emergency leaves no time for notice and comment – just as the agencies have done here,” the plaintiffs argued in a reply brief. (The plaintiffs cited Air Transp. Ass’n of Am. v. DOT.)

The administration’s attorney said the agency was looking at the pace of recovery and long-term unemployment. Hughes argued DHS did not cite long-term unemployment in its rule, and DOL would have known about long-term unemployment as a consequence months ago. Besides, plaintiffs argued, the unemployment rate has improved significantly since April.

Hughes argued the two rules were on the administration’s agenda for years, and the emergency was the 2020 election (i.e., not an acceptable reason for a “good cause” exception). He also noted to make its case on unemployment, the administration cited an article back on March 27, 2020, but that since that time, DHS and DOL had published several rules that had nothing to do with H-1B visas, further evidence of a lack of emergency that warrants a good cause exception.

Fourth, the Department of Labor stated in its rule that companies would rush to submit labor condition applications (LCAs) under the rules in place for the past 16 years if companies had “[a]dvance notice of the intended changes.” Alexandra Saslaw, representing the administration, argued, “This is a case where the agency [DOL] has significant expertise regulating businesses, and they’re using their predictive judgment to determine what those businesses might do in response to a very clear economic incentive.”

Hughes responded that precedent shows “predictive judgment alone” is not enough for an agency. There also has to be evidence. More pointedly, Hughes said, “We don’t think this argument advances the government’s position because it relies on the notion that they had to keep the DOL rule change a secret, but the government didn’t keep it a secret.” He pointed out not once, but twice, the Trump administration declared it intended the Department of Labor to impose a rule virtually identical to the rule it published. The first time came in a press call with reporters on June 22nd and the second time, on August 2nd, the president mentioned the upcoming regulation during an Oval Office media event.

It is never easy to block government regulations by convincing a court to vacate them. On behalf of the plaintiffs, Paul Hughes appeared to make the stronger legal and factual arguments. Judge White will decide if what plaintiffs describe as an “overt attempt to destroy the H-1B program” will be stopped.

 

For information as to how Relocation Africa can help you with your Mobility, Immigration, Research, Remuneration, and Expat Tax needs, email info@relocationafrica.com, or call us on +27 21 763 4240.

Sources: [1], [2]. Image sources: [1], [2].

The future of South Africa’s energy supply could be shaped by a cash injection from the United States of America. The government, in their ongoing discussions with NEDLAC and foreign investors, has entertained the idea of letting an international development firm finance and build a new nuclear power plant in South Africa.

As Bloomberg has confirmed, The US International Development Finance Corp (DFC) has signed a letter of intent to support plans laid out by NuScale, an American technology group that are ready to kick on with this project.

Amongst the billions of dollars they’ve pledged to South Africa, a ‘secure, reliable energy supply through the construction of new nuclear plants’ is their major priority.

The DFC released a statement last week, confirming that they would be pioneering in their ambitious blueprint. Should a new nuclear plant get the green light, this would be the first IPP funded by the USA throughout the whole of Africa.

“If the United States International Development Finance Corp is successful, NuScale would be the first U.S. nuclear energy IPP on the continent and would help support energy resilience and security in one of Africa’s leading economies.”

– Statement from the DFC

It’s understood that the DFC would go further than just building a new nuclear power plant in South Africa. It’s reported that their investment would plough billions into private infrastructure and public transport ‘between now and 2022’:

  • The construction of a billion-rand plant tops their agenda, providing a further 2 500 megawatts of power in South Africa.
  • The DFC has signed a letter of intent to support NuScale’s bid for South Africa’s independent power producer program.
  • The draft envisages R23 billion ($1.4 billion) being allocated to galvanize private investment in infrastructure.
  • A further R4.5 billion would be spent on public transport development over the next 12 months.

 

For information as to how Relocation Africa can help you with your Mobility, Immigration, Research, Remuneration, and Expat Tax needs, email info@relocationafrica.com, or call us on +27 21 763 4240.

Sources: [1], [2]. Image sources: [1], [2].

American vaccine development company Novavax says it has begun a Phase 2b clinical trial in South Africa to evaluate the efficacy of a Covid-19 vaccine candidate.

Dr Shabir Madhi, professor of Vaccinology at Wits University, will lead the clinical trial which is supported in part by a $15 million grant from the Bill & Melinda Gates Foundation, the company said in a statement on Monday (17 August).

“Because South Africa is experiencing a winter surge of Covid-19 disease, this important Phase 2b clinical trial has the potential to provide an early indication of efficacy, along with additional safety and immunogenicity data for NVX-CoV2373,” said Gregory M. Glenn, president of Research and Development at Novavax.

“We appreciate the continued support of the Bill & Melinda Gates Foundation and CEPI, and our strong ongoing collaboration with Wits University, all of whom are united with us in our commitment to produce and deliver a safe, effective vaccine across the globe.”

Novavax said that the trial will consist of two cohorts.  The first cohort will evaluate efficacy, safety and immunogenicity in approximately 2,665 healthy adults.

The second cohort will evaluate safety and immunogenicity in approximately 240 medically stable, HIV-positive adults. This allows for evaluation of the vaccine across a diverse, representative study population, it said.

Novavax expects that, if approved in South Africa, its Covid-19 vaccine will ultimately be supplied to in the country through a recently announced collaboration with the Serum Institute of India.

“The major motivation for the Covid-19 vaccines being evaluated at an early stage in South Africa is to generate evidence in the African context on how well these vaccines work in settings such as our own,” said Madhi.

“I am pleased to work with Novavax as the principal investigator in this clinical trial, following Novavax’ Covid-19 vaccine’s positive Phase 1 data, which provides strong rationale for moving development forward in a larger subset of adults.”

For information as to how Relocation Africa can help you with your Mobility, Immigration, Research, Remuneration, and Expat Tax needs, email info@relocationafrica.com, or call us on +27 21 763 4240.

Sources: [1], [2]. Image sources: [1], [2].

The Trump administration is changing a key exemption to America’s trade laws to make it easier to penalize about two dozen developing countries including China, India and South Africa. The announcement means that South Africa has effectively been removed from a list of nations that can receive preferential trade benefits and is now likely to attract higher import duties and levies to the US market.

It may also see the manufacturing sector losing billions of rand in revenue. Speaking to IOL, the National Association of Automobile Manufacturers of South Africa (Naamsa) said the move was a tragedy for the industry and economy as all preferential treatment was crucial.

“The US has been one of South Africa’s top export destinations and trading partners for the past three decades,” said Naamsa executive manager Norman Lamprecht. “In 2019, a total of 12,437 vehicles were exported to the US along with automotive components to the value of R4.8 billion.”

More changes incoming?

South Africa is also facing another US-related change due to the draft Copyright Amendment and Performers’ Protection Bills. The proposed legislation is a point of significant controversy because it could damage South Africa’s trade relations with the US as it is seen to violate terms of the Generalised System of Preferences (GSP) under the US Trade Act.

The Office of the United States Trade Representative is now holding public hearings in Washington D.C. on South Africa’s eligibility for the GSP program. The country’s eligibility for the GSP program has been called into question as a result of the passing of the Copyright Amendment Bill in parliament last year.

If South Africa loses its GSP eligibility, the country will potentially lose up to R34 billion in export revenue, the Copyright Coalition of South Africa (CCSA) has warned. The office of the United States Trade Representative said in October 2019 that it would review South Africa’s eligibility to participate in its GSP based on a petition it had received. The GSP is the largest and oldest US trade preference program.

It is designed to promote economic development by allowing duty-free entry into the United States for 3,500 products from the 119 designated beneficiary countries and territories. To remain eligible for these advantages, beneficiary countries must comply with 15 statutory eligibility criteria that are important to US interests, including taking steps to afford internationally recognized labor rights, providing adequate and effective protection of intellectual property rights, and assuring equitable and reasonable access to its markets.

“Coupled with the threat of losing our Generalized System of Preference (GSP) over the Copyright Amendment Bill and the distinct possibility that the US Congress will not renew the African Growth and Opportunity Act (AGOA), South Africa is heading towards a perfect trade storm with the United States which will cost us billions of rands and thousands of jobs,” said the DA’s Dean Macpherson.

 

For information as to how Relocation Africa can help you with your Mobility, Immigration, Research, Remuneration, and Expat Tax needs, email info@relocationafrica.com, or call us on +27 21 763 4240.

Sources: [1], [2]. Image sources: [1], [2].